# Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC

> **NCT05951127** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 141 (estimated)

## Conditions studied

- Esophageal Squamous Cell Carcinoma
- Oligometastatic Disease

## Interventions

- **PROCEDURE:** Esophagectomy

## Key facts

- **NCT ID:** NCT05951127
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-01
- **Primary completion:** 2027-10-31
- **Final completion:** 2027-10-31
- **Target enrollment:** 141 (ESTIMATED)
- **Last updated:** 2023-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05951127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05951127, "Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05951127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*